Also indexed as: Apo-Carbamazepine®, Apo-Primidone®,
Carbamazepine, Carbatrol, Celontin®, Dilantin®, Epanutin®, Epitol,
Ethosuximide, Ethotoin, Felbamate, Felbatol®, Fosphentyoin, Keppra®, Lamictal®,
Lamotrigine, Levetiracetam, Mesantoin®, Methsuximide, Milontin®, Mysoline®,
Novo-Carbamaz®, Nu-Carbamazepine®, Oxcarbazepine, Peganone®, Phenobarbital
(Anticonvulsants), Phensuximide, Phenytoin, Primaclone, Primidone, Taro-Carbamazepine®,
Tegretol®, Teril®, Timonil®, Topamax®, Topiramate, Tridione®,
Trileptal®, Trimethadione, Zarontin®, Zonegran®, Zonisamide

Anticonvulsants are a family of drugs that depress abnormal nerve activity in the brain,
thereby blocking seizures. Barbiturates and benzodiazepines are commonly used to prevent and
treat seizure disorders, as well as other
conditions. Though some people are maintained on a single drug, most take two or more
anticonvulsant medications to prevent seizures. Consequently, many studies report interactions
that occur in individuals taking several anticonvulsants.
Interactions that occur with multiple drug therapy are described on this page. For
interactions involving a specific anticonvulsant, refer to the highlighted drugs listed
below.
Barbiturates
Benzodiazepines
GABA Analogues
Hydantoins
- Ethotoin (Peganone®)
- Fosphentyoin (Mesantoin®)
- Phenytoin (Dilantin®)
Oxazolidinediones
- Trimethadione (Tridione®)
Phenyltriazines
Succinimides
- Ethosuximide (Zarontin®)
- Methsuximide (Celontin®)
- Phensuximide (Milontin®)
Miscellaneous
- Acetazolamide (Diamox®)
- Carbamazepine (Carbatrol®, Tegretol®)
- Felbamate (Felbatol®)
- Levetiracetam (Keppra®)
- Oxcarbazepine (Trileptal®)
- Primidone (Mysoline®)
- Topiramate (Topamax®)
- Valproic acid (Depakene®,
Depakote®)
- Zonisamide (Zonegran®)
Summary of
Interactions with Vitamins, Herbs, and Foods
In some cases, a herb or supplement may appear in more than one category, which may seem
contradictory. For clarification, read the full article for details about the summarized
interactions.
May be Beneficial: Depletion or
interference—The medication may deplete or interfere with the absorption or
function of the nutrient. Taking these nutrients may help replenish them. |
Biotin
Calcium
Folic acid
L-Carnitine
Vitamin A
Vitamin B12
Vitamin B6
Vitamin D
Vitamin K
|
May be Beneficial: Side effect
reduction/prevention—Taking these supplements may help reduce the likelihood and/or
severity of a potential side effect caused by the medication. |
Folic acid
L-Carnitine
Vitamin B12
Vitamin D
Vitamin K
|
May be Beneficial: Supportive
interaction—Taking these supplements may support or otherwise help your medication
work better. |
Folic acid
|
Avoid: Adverse interaction—Avoid these supplements when taking this
medication because taking them together may cause undesirable or dangerous results. |
Folic acid
|
| Reduced drug
absorption/bioavailability |
None known
|
| Interactions common to many, if not all,
Anticonvulsants are described in this article. Interactions reported for only one or several
drugs in this class may not be listed in this article. Some drugs listed in this article are
linked to articles specific to that respective drug; please refer to those individual drug
articles. The information in this article may not necessarily apply to drugs in this class for
which no separate article exists. If you are taking an Anticonvulsant for which no separate
article exists, talk with your doctor or chemist. |
An asterisk (*) next to an item in the summary indicates that the
interaction is supported only by weak, fragmentary, and/or contradictory scientific
evidence.
Interactions with Dietary Supplements
Biotin
Several controlled studies have shown that long-term anticonvulsant treatment decreases blood
levels of biotin.1 2 3 4 In children, a deficiency
of biotin can lead to withdrawn behaviour and a delay in mental development. Adults with low
biotin levels might experience a loss of appetite, feelings of discomfort or uneasiness,
mental depression, or hallucinations. To avoid
side effects, individuals taking anticonvulsants should supplement with biotin either alone or
as part of a multivitamin.
Calcium
Individuals on long-term multiple anticonvulsant therapy may develop below-normal blood levels
of calcium, which may be related to drug-induced
vitamin D deficiency.5 Two infants born to women taking high doses of phenytoin
and phenobarbital while pregnant developed
jitteriness and tetany (a syndrome characterised by muscle twitches, cramps, and spasm) during
the first two weeks of life.6 Controlled research is needed to determine whether pregnant women who are taking anticonvulsant
medications should supplement with additional amounts of calcium and vitamin D.
L-Carnitine
Several controlled and preliminary studies showed that multiple drug therapy for seizures results in dramatic reductions in blood
carnitine levels.7 8 9 Further controlled research is needed
to determine whether children taking anticonvulsants might benefit by supplementing with
L-carnitine, since current studies yield conflicting results. For example, one controlled
study indicated that children taking valproic
acid and carbamazepine received no benefit from supplementing with
L-carnitine.10 However, another small study revealed that children taking valproic
acid experienced less fatigue and excessive sleepiness following L-carnitine
supplementation.11 Despite the lack of well-controlled studies, individuals who are
taking anticonvulsants and experiencing side effects might benefit from supplementing with
L-carnitine.
Folic
acid
Several studies have shown that multiple anticonvulsant therapy reduces blood levels of folic
acid and dramatically increases homocysteine
levels.12 13 14 Homocysteine, a potential marker for folic
acid deficiency, is a compound used experimentally to induce seizures and is associated with
atherosclerosis. Carbamazepine alone has also
been shown to reduce blood levels of folic acid.15
One preliminary study showed that pregnant
women who use anticonvulsant drugs without folic acid supplementation have an increased risk
of having a child with birth defects, such as
heart defects, cleft lip and palate, neural tube defects, and skeletal abnormalities. However,
supplementation with folic acid greatly reduces the risk.16 Consequently, some
healthcare practitioners recommend that women taking multiple anticonvulsant drugs supplement
with 5 mg of folic acid daily, for three months prior to conception and during the first
trimester, to prevent folic acid deficiency-induced birth defects.17 Other
practitioners suggest that 1 mg or less of folic acid each day is sufficient to prevent
deficiency during pregnancy.18
One well-controlled study showed that adding folic acid to multiple anticonvulsant therapy
resulted in reduced seizure frequency.19 In addition, three infants with seizures
who were unresponsive to medication experienced immediate relief following supplementation
with the active form of folic acid.20
Despite the apparent beneficial effects, some studies have indicated that as little as 0.8
mg of folic acid taken daily can increase the frequency and/or severity of
seizures.21 22 23 24 However, a recent controlled
study showed that both healthy and epileptic women taking less than 1 mg of folic acid per day
had no increased risk for seizures.25 Until more is known about the risks and
benefits of folic acid, individuals taking multiple anticonvulsant drugs should consult with
their doctor before supplementing with folic acid. In addition, pregnant women or women who
might become pregnant while taking anticonvulsant drugs should discuss folic acid
supplementation with their practitioner.
Vitamin
A
Anticonvulsant drugs can occasionally cause birth
defects when taken by pregnant women, and
their toxicity might be related to low blood levels of vitamin A. One controlled study showed
that taking multiple anticonvulsant drugs results in dramatic changes in the way the body
utilizes vitamin A.26 Further controlled research is needed to determine whether
supplemental vitamin A might prevent birth defects in children born to women on multiple
anticonvulsant therapy. Other research suggests that ingestion of large amounts of vitamin A
may promote the development of birth defects, although the studies are conflicting.
Vitamin
B6
One controlled study revealed that taking anticonvulsant drugs dramatically reduces blood
levels of vitamin B6.27 A nutritional deficiency of vitamin B6 can lead to an
increase in homocysteine blood levels, which
has been associated with atherosclerosis.
Vitamin B6 deficiency is also associated with symptoms such as dizziness, fatigue, mental depression, and seizures. On the other hand,
supplementation with large amounts of vitamin B6 (80–200 mg per day) has been reported
to reduce blood levels of some anticonvulsant drugs, which could theoretically trigger
seizures. People taking multiple anticonvulsant drugs should discuss with their doctor whether
supplementing with vitamin B6 is advisable.
Vitamin
B12
Anaemia is an uncommon side effect experienced by people taking anticonvulsant drugs. Though
many researches believe that low blood levels of
folic acid are involved, the effects might be caused by a vitamin B12 deficiency.
Deficiencies of folic acid and vitamin B12 can lead to nerve and mental problems. One study
revealed that individuals on long-term anticonvulsant therapy, despite having no laboratory
signs of anaemia, had dramatically lower levels of vitamin B12 in their cerebrospinal fluid
(the fluid that bathes the brain) when compared with people who were not taking seizure
medications. Improvement in mental status and nerve function was observed in a majority of
symptomatic individuals after taking 30 mcg of vitamin B12 daily for a few days.28
Another study found that long-term anticonvulsant therapy had no effect on blood levels of
vitamin B12.29 The results of these two studies indicate that people taking
anticonvulsant drugs might experience side effects of vitamin B12 deficiency, and that the
deficiency is not easily detected by the usual blood tests. Therefore, individuals taking
anticonvulsant drugs for several months or years might prevent nerve and mental problems by
supplementing with vitamin B12.
Vitamin
D
Though research results vary, long-term use of anticonvulsant drugs appears to interfere with
vitamin D activity, which might lead to softening of bones (osteomalacia). One study showed that blood levels of
vitamin D in males taking anticonvulsants were lower than those found in men who were not
taking seizure medication.30 In a controlled study, bone strength improved in
children taking anticonvulsant drugs who were supplemented with the activated form of vitamin
D and 500 mg per day of calcium for nine
months.31 Some research suggests that differences in exposure to
sunlight—which normally increases blood levels of vitamin D—might explain why some
studies have failed to find a beneficial effect of vitamin D supplementation. In one
controlled study, blood vitamin D levels in children taking anticonvulsants were dramatically
lower in winter months than in summer months.32 Another study of 450 people in
Florida taking anticonvulsants found that few had drug-induced bone disease.33
Consequently, people taking anticonvulsant drugs who do not receive adequate sunlight should
supplement with 400 IU of vitamin D each day to help prevent osteomalacia.
Vitamin
E
Two studies showed that individuals taking phenytoin and phenobarbital had lower blood vitamin E levels than
those who received no treatment for seizures.34 35 Though the
consequences of lower blood levels of vitamin E are unknown, people taking multiple
anticonvulsant drugs should probably supplement with 100 to 200 IU of vitamin E daily to
prevent a deficiency.
Vitamin
K
Some studies have shown that babies born to women taking anticonvulsant drugs have low blood
levels of vitamin K, which might cause bleeding in the infant.36 Though some
researchers recommend vitamin K supplementation prior to delivery,37 38
not all agree that supplementation for women taking anticonvulsant drugs is
necessary.39 Until more information is available, pregnant women or women who might become pregnant
while taking anticonvulsant drugs should discuss vitamin K supplementation with their
doctor.
References
(To view, roll mouse over heading; to hide, click on heading)
1. Mock DM, Dyken ME. Biotin catabolism is accelerated in adults
receiving long-term therapy with anticonvulsants. Neurology 1997;49:1444–7.
2. Mock DM, Mock NI, Nelson RP, Lombard KA. Disturbances in biotin
metabolism in children undergoing long-term anticonvulsant therapy. J Pediatr
Gastroenterol Nutr 1998;26:245–50.
3. Krause KH, Bonjour JP, Berlit P, Kochen W. Biotin status of
epileptics. Ann NY Acad Sci 1985;447:297–313.
4. Krause KH, Bonjour JP, Berlit P, et al. Effect of long-term treatment
with antiepileptic drugs on the vitamin status. Drug Nutr Interact
1988;5:317–43.
5. Bouillon R, Reynaert J, Claes JH, et al. The effect of anticonvulsant
therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin
Endocrinol Metab 1975;41:1130–5.
6. Friis B, Sardemann H. Neonatal hypocalcaemia after intrauterine
exposure to anticonvulsant drugs. Arch Dis Child 1977;52:239–41.
7. Hiraoka A, Arato T, Tominaga I. Reduction in blood free carnitine
levels in association with changes in sodium valproate (VPA) disposition in epileptic patients
treated with VPA and other anti-epileptic drugs. Biol Pharm Bull
1997;20:91–3.
8. Morita J, Yuge K, Yoshino M. Hypocarnitinemia in the handicapped
individuals who receive a polypharmacy of antiepileptic drugs. Neuropediatrics
1986;17:203–5.
9. Hug G, McGraw CA, Bates SR, Landrigan EA. Reduction of serum carnitine
concentrations during anticonvulsant therapy with phenobarbitol, valproic acid, phenytoin and
carbamazepine in children. J Pedr 1991;119:799–802.
10. Freeman JM, Vining EP, Cost S, Singhi P. Does carnitine
administration improve the symptoms attributed to anticonvulsant medications?: A
double-blinded, crossover study. Pediatrics 1994;93:893–5.
11. Van Wouwe JP. Carnitine deficiency during valproic acid treatment.
Int J Vitam Nutr Res 1995;65:211–4.
12. Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and
valproate on folate metabolism in man. Acta Neurol Scand 1984;69:226–31.
13. Apeland T, Mansoor MA, Strandjord RE, Kristensen O. Homocysteine
concentrations and methionine loading in patients on antiepileptic drugs. Acta Neurol
Scand 2000;101:217–23.
14. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
15. Apeland T, Mansoor MA, Strandjord RE, et al. Folate, homocysteine and
methionine loading in patients on carbamazepine. Acta Neurol Scand
2001;103:294–9.
16. Biale Y, Lewenthal H. Effect of folic acid supplementation on
congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod
Biol 1984;18:211–6.
17. Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy.
Drugs 1999;57:535–44 [review].
18. Hiilesmaa VK, Teramo K, Granstrom JL, et al. Serum folate
concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug
concentrations, number of seizures, and fetal outcome. Br Med J (Clin Res Ed)
1983;287:577–9.
19. Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the
frequency of epileptic attacks. Eur J Clin Pharmacol 1981;19:57–60.
20. Torres OA, Miller VS, Buist NM, Hyland K. Folinic acid-responsive
neonatal seizures. J Child Neurol 1999;14:529–32.
21. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and
severity in relation to folic acid administration. Eur J Neurol
1998;5:301–3.
22. Lewis DP, Van Dyke DC, Willhite LA. Phenytoin-folic acid interaction.
Ann Pharmacother 1995;29:726–35 [review].
23. Berg MJ, Rivey MP, Vern BA, et al. Phenytoin and folic acid:
individualized drug-drug interaction. Ther Drug Monit 1983;5:395–9.
24. Reynolds EH. Effects of folic acid on the mental state and fit
frequency of drug treated epileptic patients. Lancet 1967;1:1086.
25. Eros E, Geher P, Gomor B, Czeizel AE. Epileptogenic activity of folic
acid after drug induces SLE (folic acid and epilepsy). Eur J Obstet Gynecol Reprod
Biol 1998;80:75–8.
26. Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter
endogenous retinoid concentrations: a possible mechanism of teratogensis of anticonvulsant
therapy. Life Sci 1995;57:53–60.
27. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
28. Frenkel EP, McCall MS, Sheehan RG. Cerebrospinal fluid folate, and
vitamin B12 in anticonvulsant-induced megaloblastosis. J Lab Clin Med
1973;81:105–15.
29. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
30. Telci A, Cakatay U, Kurt BB, et al. Changes in bone turnover and
deoxypyridinoline levels in epileptic patients Clin Chem Lab Med 2000
38:47–50.
31. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and
calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev
Med Child Neurol 2000;42:403–5.
32. Riancho JA, Del Arco C, Arteaga R, et al. Influence of solar
irradiation on vitamin D levels in children on anticonvulsant drugs. Acta Neurol
Scand 1989;79:296–9.
33. Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and
anticonvulsant therapy: effect of sunshine on incidence of osteomalacia. South Med J
1984;77:834.
34. Higashi A, Tamari H, Ikeda T, et al. Serum vitamin E concentration in
patients with severe multiple handicaps treated with anticonvulsants. Pediatr Pharmacol
(New York) 1980;1:129–34.
35. Higashi A, Ikeda T, Matsukura M, Matsuda I. Serum zinc and vitamin E
concentrations in handicapped children treated with anticonvulsants. Dev Pharmacol
Ther 1982;5:109–13.
36. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased
incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol 1993;168:923–8.
37. Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy.
Drugs 1999;57:535–44 [review].
38. Cornelissen M, Steegers-Theunissen R, Kollee L, et al.
Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents
neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168:884–8.
39. Hey E. Effect of maternal anticonvulsant treatment on neonatal blood
coagulation. Arch Dis Child Fetal Neonatal Ed 1999;81:F208–10.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Please read the
disclaimer about the limitations of the information provided here. Do NOT rely solely on
the information in this article.
Learn more about Healthnotes, the
company.
Learn more about the authors of Using Medicines
with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.